BAX - Baxter International Inc.
| Previous Close | 92.57 |
| Open | 92.90 |
| Bid | 92.76 x 1000 |
| Ask | 94.40 x 2900 |
| Day's Range | 91.90 - 93.43 |
| 52 Week Range | 72.42 - 95.00 |
| Volume | 1,740,189 |
| Avg. Volume | 2,466,850 |
| Market Cap | 47.553B |
| Beta (5Y Monthly) | 0.93 |
| PE Ratio (TTM) | 31.17 |
| EPS (TTM) | 2.99 |
| Earnings Date | Feb 19, 2020 - Feb 26, 2020 |
| Forward Dividend & Yield | 0.88 (0.94%) |
| Ex-Dividend Date | Dec 04, 2019 |
| 1y Target Est | 95.13 |
- GuruFocus.com
Al Gore's Generation Investment Management Buys 4 Stocks in the 4th Quarter
Former US vice president’s firm releases portfolio Continue reading...
- Zacks
Baxter (BAX) and COSMED Receive FDA Clearance for Q-NRG+
The latest FDA clearance is likely to boost Baxter's (BAX) Clinical Nutrition segment.
- Business Wire
Baxter and COSMED Announce U.S. FDA 510(k) Clearance of Q-NRG+ Indirect Calorimetry Device
Baxter International Inc., a global leader in clinical nutrition, today announced the U.S. Food and Drug Administration (FDA) clearance of Q-NRG+.
- MoneyShow
Three Trends for 2020- Dividend Growth, Sustainable Impact and the Election
There are several positive factors supporting a continuation of the bull market that began in March 2009: interest rates are low, GDP growth is consistent and solid, earnings are poised to grow, and valuations are not yet overly stretched, forecasts John Eade, chairman and CEO of Argus Research Group.
- GlobeNewswire
Baxter and Spectral Medical Announce Exclusive Distribution Agreement for Blood Filter in U.S. and Canada
Baxter International Inc. (BAX), a leading global medical products company, and Spectral Medical Inc. (EDT.TO), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced a distribution agreement for TORAYMYXIN™ PMX-20R (PMX), a hemoperfusion filter, and the Endotoxin Activity Assay™ (EAA), an on-market companion diagnostic tool that aids in the risk assessment of ICU patients for progression to severe sepsis. PMX is an investigational device in the U.S. that removes endotoxin, which contributes to sepsis, from the bloodstream.
- Zacks
Medical Products' Jan 30 Earnings Roster: TMO, EW & More
Despite the ongoing US-China trade war, solid growth in emerging markets is likely to have contributed to the performance of the players in the medical products space this earnings season.
- GlobeNewswire
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Baxter International, Acer Therapeutics, iRobot, and Prudential Financial and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, is investigating certain officers and directors of Baxter International, Inc. (BAX), Acer Therapeutics, Inc. (ACER), iRobot Corporation (IRBT), and Prudential Financial (PRU) on behalf of long-term stockholders. Bragar Eagel & Squire is investigating certain officers and directors of Baxter International, Inc. following a class action complaint that was filed against Baxter on November 25, 2019. The complaint alleges that throughout the class period, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts, about the Company’s business and operations.
- GuruFocus.com
Urbem's 'Wonderful Business' Series: Atrion
Small markets can produce attractive returns Continue reading...
- Zacks
Baxter (BAX) to Report Q4 Earnings: What's in the Cards?
Higher revenues, solid product portfolio and strong performance across six global business units are likely to have benefited Baxter's (BAX) Q4 earnings.
- GuruFocus.com
5 US and Asian Health Care Companies With Good Financial Strength
Stocks to consider as China coronavirus outbreak pressures markets Continue reading...
- ACCESSWIRE
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BAX, PTLA and GERN
NEW YORK, NY / ACCESSWIRE / January 24, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. ...
- ACCESSWIRE
FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Baxter International Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / January 24, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces it has filed a class action lawsuit against Baxter International Inc. ("Baxter" or "the Company") (NYSE:BAX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 21, 2019 and October 23, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before January 24, 2020.
- ACCESSWIRE
CLASS ACTION UPDATE for BAX, FCAU and GERN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / January 24, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders ...
- Business Wire
FINAL DEADLINE TODAY: ROSEN, A LEADING LAW FIRM, Reminds Baxter International Inc. Investors of Important January 24th Deadline in Securities Class Action
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Baxter International Inc. (NYSE: BAX) between February 21, 2019 and October 23, 2019, inclusive (the "Class Period"), of the important January 24, 2020 lead plaintiff deadline in the case. The lawsuit seeks to recover damages for Baxter investors under the federal securities laws.
- ACCESSWIRE
CLASS ACTION UPDATE for GDOT, BAX and HEXO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / January 24, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders ...
- GlobeNewswire
BAXTER DEADLINE ALERT: FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Deadline in Class Action Lawsuit Against Baxter International Inc. - BAX
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only until January 24, 2020 to file lead plaintiff applications in a securities class action lawsuit against Baxter International Inc. (BAX), if they purchased the Company’s shares between February 21, 2019, and October 23, 2019, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of Illinois. If you purchased shares of Baxter and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nyse-bax/ to learn more.
- ACCESSWIRE
SHAREHOLDER ALERT: BAX HEXO PTLA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, NY / ACCESSWIRE / January 23, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a ...
- Newsfile
BAXTER SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Baxter International, Inc. To Contact The Firm
New York, New York--(Newsfile Corp. - January 23, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Baxter International, Inc. ("Baxter" or the "Company") (NYSE: BAX) of the January 24, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi logoIf you invested in Baxter stock or options between February 21, 2019 and October ...
- ACCESSWIRE
CLASS ACTION UPDATE for BAX, FCAU and XYF: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / January 23, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders ...
- GlobeNewswire
DEADLINE ALERT - Baxter International Inc. (BAX) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors With Losses Exceeding $100K of Class Action and Lead Plaintiff Deadline: January 24, 2020
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Baxter International Inc. (“Baxter” or the “Company”) (BAX) and certain of its officers, on behalf of shareholders who purchased Baxter securities between February 21, 2019 and October 23, 2019, inclusive (the “Class Period”). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
- Zacks
What's in Store for Varian Medical (VAR) in Q1 Earnings?
Demand for Eclipse and TrueBeam is expected to have driven Varian's (VAR) Oncology revenues in fiscal Q1.
- GlobeNewswire
SHAREHOLDER ALERT: CLAIMSFILER REMINDS BAX, WBAI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
NEW ORLEANS, Jan. 22, 2020 -- ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits:.
- ACCESSWIRE
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GDOT, BAX and HEXO
NEW YORK, NY / ACCESSWIRE / January 22, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate ...
- ACCESSWIRE
FINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Baxter International Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / January 22, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces it has filed a class action lawsuit against Baxter International Inc. ("Baxter" or "the Company") (NYSE:BAX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 21, 2019 and October 23, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before January 24, 2020.
